Blood-Based Tests for Colorectal Cancer Screening: Do They Threaten the Survival of the FIT Test?

被引：35
作者：
Bresalier, Robert S. [1 ]
Kopetz, Scott [2 ]
Brenner, Dean E. [3 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept GI Med Oncol, Houston, TX 77030 USA
[3] Univ Michigan, Dept Med Oncol, Ann Arbor, MI 48109 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2015年 / 60卷 / 03期
关键词：
Colon cancer; Screening; Blood-based markers; Fecal occult blood testing; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED ANTIGEN; SEPTIN; 9; DNA; COLON-CANCER; GLYCOPROTEIN MICROARRAYS; BINDING PROTEIN-3; POTENTIAL MARKER; PLASMA-INSULIN; FACTOR-I; SERUM;
D O I：
10.1007/s10620-015-3575-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Colorectal cancer is the second leading cause of cancer death in industrialized nations, accounting for 10 % of the total cancer burden with an individual lifetime risk of similar to 6 % in the USA (Siegel et al. in CA Cancer J Clin 62:9-29, 2014, American Cancer Society in Colorectal cancer facts and figures 2011-2013. American Cancer Society, Atlanta, 2011, Siegel et al. in CA Cancer J Clin 61:212-236, 2011). Although numerous screening methods have been incorporated into guidelines for colorectal cancer screening, no guideline includes a noninvasive blood-based test as a recommended option.
引用
收藏
页码：664 / 671
页数：8
相关论文
共 66 条
  • [61] Loss of insulin-like growth factor-II imprinting and the presence of screen-detected colorectal adenomas in women
    Woodson, K
    Flood, A
    Green, L
    Tangrea, JA
    Hanson, J
    Cash, B
    Schatzkin, A
    Schoenfeld, P
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (05): : 407 - 410
  • [62] Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
    Yue, Tingting
    Maupin, Kevin A.
    Fallon, Brian
    Li, Lin
    Partyka, Katie
    Anderson, Michelle A.
    Brenner, Dean E.
    Kaul, Karen
    Zeh, Herbert
    Moser, A. James
    Simeone, Diane M.
    Feng, Ziding
    Brand, Randall E.
    Haab, Brian B.
    [J]. PLOS ONE, 2011, 6 (12):
  • [63] Serologic Autoantibodies as Diagnostic Cancer Biomarkers-A Review
    Zaenker, Pauline
    Ziman, Melanie R.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (12) : 2161 - 2181
  • [64] Microfluidics and cancer: are we there yet?
    Zhang, Zhuo
    Nagrath, Sunitha
    [J]. BIOMEDICAL MICRODEVICES, 2013, 15 (04) : 595 - 609
  • [65] Glycoprotein microarrays with multi-lectin detection: Unique lectin binding patterns as a tool for classifying normal, chronic pancreatitis and pancreatic cancer sera
    Zhao, Jia
    Patwa, Tasneem H.
    Qiu, Weilian
    Shedden, Kerby
    Hinderer, Robert
    Misek, David E.
    Anderson, Michelle A.
    Simeone, Diane M.
    Lubman, David M.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2007, 6 (05) : 1864 - 1874
  • [66] N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis
    Zhao, Jia
    Qiu, Weilian
    Simeone, Diane M.
    Lubman, David M.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2007, 6 (03) : 1126 - 1138
1234567